$xbi

Biotech sector shows mixed signals with positive trial data and M&A buzz countered by regulatory concerns and stock volatility. Recent posts highlight upcoming clinical data and sector recovery, but caution remains.

About $xbi

$XBI refers to the SPDR S&P Biotech ETF, a benchmark for the biotechnology sector.

Engagements: [------] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-------]
[--] Month: [---------] -51%
[--] Months: [----------] +59%
[--] Year: [----------] -20%
1-Year High: [-------] on 2025-11-14
1-Year Low: [------] on 2026-02-08

Engagements by network (24h): YouTube: [--] X: [------] Reddit: [---]

Mentions: [---] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
1-Year High: [-----] on 2025-11-24
1-Year Low: [---] on 2025-09-15

Mentions by network (24h): YouTube: [--] X: [---] Reddit: [--]

Creators: [---] (24h)

Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning $xbi in the last [--] hours which is down 4.60% from [---] in the previous [--] hours Daily Average: [---]
1-Year High: [---] on 2025-11-24
1-Year Low: [--] on 2025-05-04

The most influential creators that mention $xbi in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@PersimmonTI	[--]	[------]	[--]	[------]
@yaireinhorn	[--]	[------]	[--]	[-----]
@WallStSai	[--]	[-----]	[--]	[-----]
@BOSSTRADING0	[--]	[-----]	[--]	[-----]
@BRSreality	[--]	[---]	[--]	[---]
@Andre_AGTC	[--]	[-----]	[--]	[---]
@semodough	[--]	[------]	[--]	[---]
@ej23ny	[--]	[-----]	[--]	[---]
@ShortSeller	[--]	[------]	[--]	[---]
@MACROVET888	[--]	[---]	[--]	[---]

View More

Sentiment: 80%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 82%
[--] Month: 77% +1%
[--] Months: 77% -5%
[--] Year: 77% +5%
1-Year High: 94% on 2025-04-30
1-Year Low: 67% on 2025-04-19

Most Supportive Themes:

• Positive Clinical Trial Data & FDA Approvals: (30%) Positive clinical trial results and FDA approvals are driving optimism and investment in biotech companies.
• Mergers & Acquisitions (M&A) Activity: (25%) Anticipation of mergers and acquisitions within the biotech sector is creating buying pressure and interest.
• Biotech Bull Run & Sector Growth: (20%) The overall bullish sentiment and perceived growth of the biotechnology sector are attracting investors.

Most Critical Themes:

• Regulatory Uncertainty & Delays: (35%) Concerns about regulatory hurdles, clinical holds, and potential delays are creating caution.
• Stock Price Volatility & Manipulation Concerns: (30%) High volatility in stock prices and concerns about market manipulation are leading to investor apprehension.
• Company-Specific Challenges: (20%) Individual company struggles, unexpected safety issues, or poor performance are creating negative sentiment for specific stocks.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing